General Assembly 2024 Supplement

Download our free guide

Home  >  News  >  Hospice and Bible Society Speakers at China Group Plenary

News

Hospice and Bible Society Speakers at China Group Plenary

Wednesday September 6 2023


Representatives from Strathcarron Hospice and the Scottish Bible Society will speak at the Scottish Churches China Group’s (SCCG’s) autumn plenary, in Edinburgh next week.

Formed in 1983, the SCCG’s aim is to help advance health, education and social welfare for people living in China, and to encourage and support Christian witness in China.

Among the charity’s current initiatives, is a possible innovative online project that would link Strathcarron Hospice in Denny with the palliative care ward at Shengjing Hospital, Shenyang in northeast China, for sharing expertise and mutual learning.

The plenary will hear from Dr Sally Boa, Head of Education, Research and Practice Development at Strathcarron, who has visited Shengjing to run a training course for rehabilitation staff, and has overseen two-week placements for staff from Shengjing. She will co-present with Dr Gill Foster, Medical Lead and Consultant in Palliative Medicine at the hospice.

Also speaking will be Norman Liddle, Community Partnership Manager with the Scottish Bible Society, which has strong links with the SCCG partner the Amity Foundation, which prints Bibles in Chinese.

The morning will also provide an opportunity to get a brief update about the projects the SCCG is involved in with partners in China in Shenyang, Shanghai and Nanjing. These include projects supporting children with additional educational support needs and elderly and dementia care by local Chinese church organisations.

The event is on Thursday September 14, starting at 10.30am, at the Cornerstone Centre at St John's Episcopal Church, Princes St, Edinburgh. It is a public event and all are welcome. Lunch is provided and you can advise of dietary requirements to patricia.johnston@sccg.org.uk 


Life and Work is the magazine of the Church of Scotland. Subscribe here.


Comments

There are currently no comments on this post


Add a reply

All fields are required. Email address will not be published.